These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 36638038)

  • 21. Treadmill training in patients affected by Charcot-Marie-Tooth neuropathy: results of a multicenter, prospective, randomized, single-blind, controlled study.
    Mori L; Signori A; Prada V; Pareyson D; Piscosquito G; Padua L; Pazzaglia C; Fabrizi GM; Picelli A; Schenone A;
    Eur J Neurol; 2020 Feb; 27(2):280-287. PubMed ID: 31444929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dosage ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A: results of a randomized, double-masked, controlled trial.
    Lewis RA; McDermott MP; Herrmann DN; Hoke A; Clawson LL; Siskind C; Feely SM; Miller LJ; Barohn RJ; Smith P; Luebbe E; Wu X; Shy ME;
    JAMA Neurol; 2013 Aug; 70(8):981-7. PubMed ID: 23797954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Charcot-Marie-Tooth disease and related inherited neuropathies.
    Murakami T; Garcia CA; Reiter LT; Lupski JR
    Medicine (Baltimore); 1996 Sep; 75(5):233-50. PubMed ID: 8862346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
    Kulkarni SD; Sayed R; Garg M; Patil VA
    Neuromuscul Disord; 2015 Nov; 25(11):916-9. PubMed ID: 26432165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotypic spectrum of Charcot-Marie-Tooth disease due to LITAF/SIMPLE mutations: a study of 18 patients.
    Guimarães-Costa R; Iancu Ferfoglia R; Leonard-Louis S; Ziegler F; Magy L; Fournier E; Dubourg O; Bouche P; Maisonobe T; Lacour A; Moerman A; Latour P; Stojkovic T
    Eur J Neurol; 2017 Mar; 24(3):530-538. PubMed ID: 28211240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance training effectiveness in patients with Charcot-Marie-Tooth disease: recommendations for exercise prescription.
    Chetlin RD; Gutmann L; Tarnopolsky M; Ullrich IH; Yeater RA
    Arch Phys Med Rehabil; 2004 Aug; 85(8):1217-23. PubMed ID: 15295743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin-cyclodextrin/cellulose nanocrystals improve the phenotype of Charcot-Marie-Tooth-1A transgenic rats through the reduction of oxidative stress.
    Caillaud M; Msheik Z; Ndong-Ntoutoume GM; Vignaud L; Richard L; Favreau F; Faye PA; Sturtz F; Granet R; Vallat JM; Sol V; Desmoulière A; Billet F
    Free Radic Biol Med; 2020 Dec; 161():246-262. PubMed ID: 32980538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motor performance deterioration accelerates after 50 years of age in Charcot-Marie-Tooth type 1A patients.
    Tozza S; Bruzzese D; Pisciotta C; Iodice R; Esposito M; Dubbioso R; Ruggiero L; Topa A; Spina E; Santoro L; Manganelli F
    Eur J Neurol; 2018 Feb; 25(2):301-306. PubMed ID: 29053907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pilot study of proximal strength training in Charcot-Marie-Tooth disease.
    Ramdharry GM; Pollard A; Anderson C; Laurá M; Murphy SM; Dudziec M; Dewar EL; Hutton E; Grant R; Reilly MM
    J Peripher Nerv Syst; 2014 Dec; 19(4):328-32. PubMed ID: 25582960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and pathological studies in Charcot-Marie-Tooth disease 1A.
    Kosuka N; Tachi N; Ohya K; Chiba S
    Brain Dev; 1997 Nov; 19(7):464-8. PubMed ID: 9408592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychoacoustics and neurophysiological auditory processing in patients with Charcot-Marie-Tooth disease types 1A and 2A.
    Choi JE; Seol HY; Seok JM; Hong SH; Choi BO; Moon IJ
    Eur J Neurol; 2020 Oct; 27(10):2079-2088. PubMed ID: 32478888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nerve conduction velocity in CMT1A: what else can we tell?
    Manganelli F; Pisciotta C; Reilly MM; Tozza S; Schenone A; Fabrizi GM; Cavallaro T; Vita G; Padua L; Gemignani F; Laurà M; Hughes RA; Solari A; Pareyson D; Santoro L;
    Eur J Neurol; 2016 Oct; 23(10):1566-71. PubMed ID: 27412484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Counter-movement jump characteristics in children with Charcot-Marie-Tooth type 1a disease.
    Alexander N; Broser PJ
    Gait Posture; 2022 Mar; 93():218-224. PubMed ID: 35183839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol [EudraCT no.: 2006-000032-27].
    Pareyson D; Schenone A; Fabrizi GM; Santoro L; Padua L; Quattrone A; Vita G; Gemignani F; Visioli F; Solari A;
    Pharmacol Res; 2006 Dec; 54(6):436-41. PubMed ID: 17029975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of comorbidities on the phenotype of patients affected by Charcot-Marie-Tooth neuropathy type 1A.
    Ursino G; Alberti MA; Grandis M; Reni L; Pareyson D; Bellone E; Gemelli C; Sabatelli M; Pisciotta C; Luigetti M; Santoro L; Massollo L; Schenone A
    Neuromuscul Disord; 2013 Nov; 23(11):902-6. PubMed ID: 23891256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome measures and rehabilitation treatment in patients affected by Charcot-Marie-Tooth neuropathy: a pilot study.
    Maggi G; Monti Bragadin M; Padua L; Fiorina E; Bellone E; Grandis M; Reni L; Bennicelli A; Grosso M; Saporiti R; Scorsone D; Zuccarino R; Crimi E; Schenone A
    Am J Phys Med Rehabil; 2011 Aug; 90(8):628-37. PubMed ID: 21681064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nerve ultrasound depicts peripheral nerve enlargement in patients with genetically distinct Charcot-Marie-Tooth disease.
    Noto Y; Shiga K; Tsuji Y; Mizuta I; Higuchi Y; Hashiguchi A; Takashima H; Nakagawa M; Mizuno T
    J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):378-84. PubMed ID: 25091364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An adapted dance program for children with Charcot-Marie-Tooth disease: An exploratory study.
    Cherriere C; Martel M; Fortin S; Raymond MJ; Veilleux LN; Lemay M
    J Bodyw Mov Ther; 2020 Apr; 24(2):85-91. PubMed ID: 32507158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rehabilitation interventions for foot drop in neuromuscular disease.
    Sackley C; Disler PB; Turner-Stokes L; Wade DT; Brittle N; Hoppitt T
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003908. PubMed ID: 19588347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic epidemiology, demographic, and clinical characteristics of Charcot-Marie-tooth disease in the island of Gran Canaria (Spain).
    Lousa M; Vázquez-Huarte-Mendicoa C; Gutiérrez AJ; Saavedra P; Navarro B; Tugores A
    J Peripher Nerv Syst; 2019 Mar; 24(1):131-138. PubMed ID: 30569560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.